Brief: Beam Announces Agreement For Lilly To Acquire Beam’S Opt-In Rights To Verve Therapeutics’ Base Editing Programs

Beam Therapeutics

31/10/2023 10:24

Oct 31 (Reuters) - Beam Therapeutics Inc  BEAM.O :
    * BEAM ANNOUNCES AGREEMENT FOR LILLY TO ACQUIRE BEAM’S
OPT-IN
RIGHTS TO VERVE THERAPEUTICS’ BASE EDITING PROGRAMS FOR
CARDIOVASCULAR DISEASE
    * BEAM THERAPEUTICS INC - UNDER TERMS OF AGREEMENT, BEAM
WILL
RECEIVE A $200 MILLION UPFRONT PAYMENT AND $50 MILLION EQUITY
INVESTMENT
    * BEAM THERAPEUTICS:TO GET UP TO $350 MILLION IN POTENTIAL
FUTURE
DEVELOPMENT-STAGE PAYMENTS UPON COMPLETION OF CERTAIN CLINICAL,
REGULATORY, ALLIANCE EVENTS
    * BEAM THERAPEUTICS INC - PROPOSED DEAL FOR TOTAL OF UP TO
$600
MILLION IN POTENTIAL TOTAL DEAL CONSIDERATION

Source text for Eikon:  ID:nGNXbKPtwG 
Further company coverage:  BEAM.O 

 ((Reuters.Briefs@thomsonreuters.com;))